Cargando…

Metabolic control of epigenetic rearrangements in B cell pathophysiology

Both epigenetic and metabolic reprogramming guide lymphocyte differentiation and can be linked, in that metabolic inputs can be integrated into the epigenome to inform cell fate decisions. This framework has been thoroughly investigated in several pathophysiological contexts, including haematopoieti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calciolari, Beatrice, Scarpinello, Greta, Tubi, Laura Quotti, Piazza, Francesco, Carrer, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113833/ https://www.ncbi.nlm.nih.gov/pubmed/35580618 http://dx.doi.org/10.1098/rsob.220038

Ejemplares similares

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
por: Manni, Sabrina, et al.
Publicado: (2022)

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
por: Manni, Sabrina, et al.
Publicado: (2021)

Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma
por: Carrino, Marilena, et al.
Publicado: (2019)

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
por: Piazza, Francesco, et al.
Publicado: (2010)

CK2β-regulated signaling controls B cell differentiation and function
por: Quotti Tubi, Laura, et al.
Publicado: (2023)

CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
por: Fregnani, Anna, et al.
Publicado: (2022)

Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity
por: Quotti Tubi, Laura, et al.
Publicado: (2013)

P1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL-2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH
por: Manni, S., et al.
Publicado: (2022)

Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells
por: Manni, Sabrina, et al.
Publicado: (2013)

The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma
por: Canovas Nunes, Sara, et al.
Publicado: (2018)

Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways
por: Manni, Sabrina, et al.
Publicado: (2017)

Chromatin and Epigenetic Rearrangements in Embryonic Stem Cell Fate Transitions
por: Sun, Li, et al.
Publicado: (2021)

Epigenetic regulation of antigen receptor gene rearrangement
por: Spicuglia, Salvatore, et al.
Publicado: (2010)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Epigenetic Enhancer Marks and Transcription Factor Binding Influence Vκ Gene Rearrangement in Pre-B Cells and Pro-B Cells
por: Kleiman, Eden, et al.
Publicado: (2018)

Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities
por: Costoya, José A., et al.
Publicado: (2022)

Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas
por: Piccaluga, Pier P., et al.
Publicado: (2018)

CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis
por: Quotti Tubi, Laura, et al.
Publicado: (2023)

Epigenetic maintenance of topological domains in the highly rearranged gibbon genome
por: Lazar, Nathan H., et al.
Publicado: (2018)

Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells
por: Lu, Jingli, et al.
Publicado: (2021)

Genetics and epigenetics as tools to inform the pathophysiology of neuropsychiatric disorders
por: Fries, Gabriel Rodrigo
Publicado: (2019)

Epigenetic Regulation in Sepsis, Role in Pathophysiology and Therapeutic Perspective
por: Falcão-Holanda, Renata Brito, et al.
Publicado: (2021)

Cytoskeletal Rearrangements in Synovial Fibroblasts as a Novel Pathophysiological Determinant of Modeled Rheumatoid Arthritis
por: Aidinis, Vassilis, et al.
Publicado: (2005)

Epigenetic Regulation of Monoallelic Rearrangement (Allelic Exclusion) of Antigen Receptor Genes
por: Levin-Klein, Rena, et al.
Publicado: (2014)

Pathophysiology of Metabolic Syndrome
por: Aganović, Izet, et al.
Publicado: (2007)

Correction: Cytoskeletal Rearrangements in Synovial Fibroblasts as a Novel Pathophysiological Determinant of Modeled Rheumatoid Arthritis
por: Aidinis, Vassilis, et al.
Publicado: (2005)

Epigenetic Alterations in Fanconi Anaemia: Role in Pathophysiology and Therapeutic Potential
por: Belo, Hélio, et al.
Publicado: (2015)

Mitochondria in migraine pathophysiology – does epigenetics play a role?
por: Fila, Michał, et al.
Publicado: (2019)

Editorial: Epigenetic, molecular and programming mechanisms of renal physiology and pathophysiology
por: Gomes, Guiomar Nascimento, et al.
Publicado: (2023)

Infrastructural capital in the Israeli vaccination campaign against COVID-19()
por: Tubi, Omri
Publicado: (2022)

Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
por: Piazza, Francesco, et al.
Publicado: (2022)

Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism
por: Aoki, Tomohiro, et al.
Publicado: (2016)

Editorial Effect of Epi-drugs on Epigenetic Modifications Induced by Environmental Pollutants: Implications for the Pathophysiology of Cancer and Endocrine/metabolic Diseases
por: Teti, Diana
Publicado: (2014)

Postmenopausal Uterine Leiomyomas and Chronic Lymphadenopathy: Exploring Epigenetic Changes and Pathophysiology
por: Grcevich, Leah O, et al.
Publicado: (2021)

New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics
por: Dothel, Giovanni, et al.
Publicado: (2023)

Editorial: Molecular Mechanisms Controlling the Metabolic Reprogramming of Immune Cells Under Pathophysiological Conditions
por: Fitzpatrick, Susan F., et al.
Publicado: (2020)

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)
por: Tisi, Maria Chiara, et al.
Publicado: (2019)

Epigenetic control of variation and stochasticity in metabolic disease
por: Panzeri, Ilaria, et al.
Publicado: (2018)

Unraveling Pathophysiology of Takotsubo Syndrome: The Emerging Role of the Oxidative Stress’s Systemic Status
por: Viceconte, Nicola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o0ups17l5a12oonog36qhoqsv3